{"id":230454,"date":"2026-09-04T11:01:44","date_gmt":"2026-09-04T05:31:44","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=230454"},"modified":"2026-09-04T11:01:45","modified_gmt":"2026-09-04T05:31:45","slug":"is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Krishna Institute of Medical Sciences a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Krishna Institute of Medical Sciences share price around Rs 766. 10.8% below 52-week high of Rs 858. Q1 FY27 revenue Rs 1,196 crore, up 36.1% YoY. PAT Rs 37 crore, down 56.0%.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">Krishna Institute of Medical Sciences&#8217; Q1 FY27 results were mixed, with revenue at Rs 1,196 crore but PAT falling 56% to Rs 37 crore. The Krishna Institute of Medical Sciences share price near Rs 766 has not escaped this pressure, and the profit decline is the key data point investors should weigh before deciding whether Krishna Institute of Medical Sciences is a good buy right now.<\/p>\n<\/div>\n<p>The Krishna Institute of Medical Sciences share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Krishna Institute of Medical Sciences is a South India-focused multi-specialty hospital chain, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n<p>Revenue for the quarter came in at Rs 1,196 crore, up 36.1% year on year, while profit after tax came in at Rs 37 crore, down 56.0% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Krishna Institute of Medical Sciences share price from here.<\/p>\n<p>This piece works through the quarter&#8217;s financial highlights, the business factors behind the numbers, where the Krishna Institute of Medical Sciences share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=krishna-institute-of-medical-sciences_q1fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Krishna_Institute_of_Medical_Sciences_Q1_FY27_Financial_Highlights\" title=\"Krishna Institute of Medical Sciences Q1 FY27 Financial Highlights\">Krishna Institute of Medical Sciences Q1 FY27 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Krishna_Institute_of_Medical_Sciences_Q1_FY27_Performance_Analysis\" title=\"Krishna Institute of Medical Sciences Q1 FY27 Performance Analysis\">Krishna Institute of Medical Sciences Q1 FY27 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Key_Business_Factors_in_Q1_FY27\" title=\"Key Business Factors in Q1 FY27\">Key Business Factors in Q1 FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Revenue_Trend\" title=\"Revenue Trend\">Revenue Trend<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Margin_Movement\" title=\"Margin Movement\">Margin Movement<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Balance_Sheet_Position\" title=\"Balance Sheet Position\">Balance Sheet Position<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Valuation_Context\" title=\"Valuation Context\">Valuation Context<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Krishna_Institute_of_Medical_Sciences_Share_Price_Outlook_for_FY27\" title=\"Krishna Institute of Medical Sciences Share Price Outlook for FY27\">Krishna Institute of Medical Sciences Share Price Outlook for FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Krishna_Institute_of_Medical_Sciences_Stock_Performance\" title=\"Krishna Institute of Medical Sciences Stock Performance\">Krishna Institute of Medical Sciences Stock Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Key_Risks\" title=\"Key Risks\">Key Risks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Profitability_Risk\" title=\"Profitability Risk\">Profitability Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Leverage_Risk\" title=\"Leverage Risk\">Leverage Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Sector_and_Demand_Risk\" title=\"Sector and Demand Risk\">Sector and Demand Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Frequently_Asked_Questions_on_Krishna_Institute_of_Medical_Sciences_Q1_FY27_Results\" title=\"Frequently Asked Questions on Krishna Institute of Medical Sciences Q1 FY27 Results\">Frequently Asked Questions on Krishna Institute of Medical Sciences Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#What_were_Krishna_Institute_of_Medical_Sciences_Q1_FY27_results\" title=\"What were Krishna Institute of Medical Sciences&#8217; Q1 FY27 results?\">What were Krishna Institute of Medical Sciences&#8217; Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Is_Krishna_Institute_of_Medical_Sciences_a_good_buy_after_its_Q1_FY27_results\" title=\"Is Krishna Institute of Medical Sciences a good buy after its Q1 FY27 results?\">Is Krishna Institute of Medical Sciences a good buy after its Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#What_is_the_Krishna_Institute_of_Medical_Sciences_share_price_today\" title=\"What is the Krishna Institute of Medical Sciences share price today?\">What is the Krishna Institute of Medical Sciences share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#What_is_Krishna_Institute_of_Medical_Sciences_revenue_and_profit_for_Q1_FY27\" title=\"What is Krishna Institute of Medical Sciences&#8217; revenue and profit for Q1 FY27?\">What is Krishna Institute of Medical Sciences&#8217; revenue and profit for Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Did_Krishna_Institute_of_Medical_Sciences_declare_a_dividend_with_its_Q1_FY27_results\" title=\"Did Krishna Institute of Medical Sciences declare a dividend with its Q1 FY27 results?\">Did Krishna Institute of Medical Sciences declare a dividend with its Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#Why_does_Krishna_Institute_of_Medical_Sciences_not_have_a_meaningful_PE_ratio\" title=\"Why does Krishna Institute of Medical Sciences not have a meaningful PE ratio?\">Why does Krishna Institute of Medical Sciences not have a meaningful PE ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#What_are_the_key_risks_for_Krishna_Institute_of_Medical_Sciences_investors_right_now\" title=\"What are the key risks for Krishna Institute of Medical Sciences investors right now?\">What are the key risks for Krishna Institute of Medical Sciences investors right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results\/#What_is_Krishna_Institute_of_Medical_Sciences_promoter_shareholding\" title=\"What is Krishna Institute of Medical Sciences&#8217; promoter shareholding?\">What is Krishna Institute of Medical Sciences&#8217; promoter shareholding?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Krishna_Institute_of_Medical_Sciences_Q1_FY27_Financial_Highlights\"><\/span><strong>Krishna Institute of Medical Sciences Q1 FY27 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse;\">\n<thead>\n<tr style=\"background: #F0F0F0;\">\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">Metric<\/th>\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">Q1 FY27<\/th>\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">Q1 FY26<\/th>\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Revenue<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 1,196 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 879 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">36.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">EBITDA<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 240 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 200 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">20.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Operating Margin<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">20.4%<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">22.9%<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">NA<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Profit Before Tax<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 57 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 114 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">-50.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Net Profit \/ (Loss)<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 37 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 85 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">-56.0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Krishna_Institute_of_Medical_Sciences_Q1_FY27_Performance_Analysis\"><\/span><strong>Krishna Institute of Medical Sciences Q1 FY27 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Krishna Institute of Medical Sciences Fundamentals on Univest Screener<\/strong><\/a><\/p>\n<p>Revenue growth of 36.1% for the quarter came from steady demand across the company&#8217;s core business, keeping the topline trend intact for the multi-specialty hospital care sector.<\/p>\n<p>Profitability is where the quarter disappointed. PAT fell 56% year on year to Rs 37 crore even as revenue grew, which points to margin or cost pressure that management will need to address. This gap between top-line and bottom-line performance is the key thing weighing on the Krishna Institute of Medical Sciences share price this quarter.<\/p>\n<p>On a sequential basis, revenue moved up 10.3% sequentially from Rs 1,084 crore in the March 2026 quarter and net profit moved up 13.0% sequentially from Rs 33 crore in the prior quarter, giving a fuller picture of the trend behind the Krishna Institute of Medical Sciences share price than the year on year comparison alone.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Q1_FY27\"><\/span><strong>Key Business Factors in Q1 FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Trend\"><\/span><strong>Revenue Trend<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Krishna Institute of Medical Sciences&#8217; revenue grew 36.1% year on year this quarter, taking the quarterly base to Rs 1,196 crore in a multi-specialty hospital care business that remains sensitive to demand and pricing cycles that ultimately feed through to the Krishna Institute of Medical Sciences share price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Margin_Movement\"><\/span><strong>Margin Movement<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>EBITDA rose 20.1% to Rs 240 crore, and operating margin moved to 20.4% from 22.9% a year earlier, a sign that cost control or pricing held up during the quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Balance_Sheet_Position\"><\/span><strong>Balance Sheet Position<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Krishna Institute of Medical Sciences&#8217; debt-to-equity ratio stands at 1.89, a level worth monitoring given the quarter&#8217;s margin trend.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_Context\"><\/span><strong>Valuation Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Krishna Institute of Medical Sciences does not carry a meaningful PE multiple this quarter given its current earnings, so investors should lean on revenue and book value trends instead of the price-to-earnings ratio when assessing the Krishna Institute of Medical Sciences share price.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No interim dividend was declared alongside Krishna Institute of Medical Sciences&#8217; Q1 FY27 results. The stock has not paid a meaningful dividend in the trailing twelve months. Investors tracking the Krishna Institute of Medical Sciences share price for income should watch the company&#8217;s announcements around its next annual results for any dividend decision.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Krishna_Institute_of_Medical_Sciences_Share_Price_Outlook_for_FY27\"><\/span><strong>Krishna Institute of Medical Sciences Share Price Outlook for FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The key question for the rest of FY27 is whether Krishna Institute of Medical Sciences can arrest the margin pressure seen this quarter. Revenue growth alone will not be enough to support the Krishna Institute of Medical Sciences share price if profitability keeps slipping, so investors should watch the next couple of quarters for signs of a turnaround in the bottom line.<\/p>\n<p>A stabilising or improving margin trend in the next result would be the clearest signal that this quarter&#8217;s profit decline was a temporary setback rather than the start of a longer slide for the Krishna Institute of Medical Sciences share price.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Krishna_Institute_of_Medical_Sciences_Stock_Performance\"><\/span><strong>Krishna Institute of Medical Sciences Stock Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Krishna Institute of Medical Sciences&#8217; live share price and get daily stock updates.<\/em><\/p>\n<p>The Krishna Institute of Medical Sciences share price was trading around Rs 766 as results season played out in late August 2026, roughly 10.8% below its 52-week high of Rs 858 and well above its 52-week low of Rs 576. Promoter holding stood at 32.5% as of the June 2026 quarter.<\/p>\n<p>The Krishna Institute of Medical Sciences share price has likely already absorbed some of this quarter&#8217;s disappointment, but further downside is possible if the next results confirm the same trend rather than a one-off. On profitability ratios, the company reports a return on equity of 10.74% and a book value of around Rs 89 per share, both useful reference points when judging whether the current price is reasonable.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks\"><\/span><strong>Key Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Profitability_Risk\"><\/span><strong>Profitability Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The quarter&#8217;s profit trend is the clearest risk here. Until Krishna Institute of Medical Sciences shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Leverage_Risk\"><\/span><strong>Leverage Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A debt-to-equity ratio of 1.89 means the company&#8217;s earnings are more sensitive to interest rate and refinancing conditions than a lower-debt peer.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Sector_and_Demand_Risk\"><\/span><strong>Sector and Demand Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As a multi-specialty hospital care business, Krishna Institute of Medical Sciences&#8217; results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Krishna Institute of Medical Sciences share price well before the next result.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Krishna Institute of Medical Sciences&#8217; Q1 FY27 results show a business still growing its top line but losing ground on profitability, with PAT down 56% to Rs 37 crore even as revenue rose. The Krishna Institute of Medical Sciences share price reflects a stock in wait-and-watch mode, and it is not an obvious buy purely on this quarter&#8217;s numbers until the margin trend turns around.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Krishna_Institute_of_Medical_Sciences_Q1_FY27_Results\"><\/span><strong>Frequently Asked Questions on Krishna Institute of Medical Sciences Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_were_Krishna_Institute_of_Medical_Sciences_Q1_FY27_results\"><\/span><strong>What were Krishna Institute of Medical Sciences&#8217; Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Krishna Institute of Medical Sciences reported Q1 FY27 revenue of Rs 1,196 crore, up 36.1% year on year, and PAT of Rs 37 crore, down 56.0% year on year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Krishna_Institute_of_Medical_Sciences_a_good_buy_after_its_Q1_FY27_results\"><\/span><strong>Is Krishna Institute of Medical Sciences a good buy after its Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Krishna Institute of Medical Sciences&#8217; profitability came under pressure this quarter, which makes this a stock to watch rather than an obvious buy purely on this result. Investors should form their own view based on their own risk appetite and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Krishna_Institute_of_Medical_Sciences_share_price_today\"><\/span><strong>What is the Krishna Institute of Medical Sciences share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Krishna Institute of Medical Sciences share price was trading around Rs 766 in late August 2026, about 10.8% below its 52-week high of Rs 858 and well above its 52-week low of Rs 576.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Krishna_Institute_of_Medical_Sciences_revenue_and_profit_for_Q1_FY27\"><\/span><strong>What is Krishna Institute of Medical Sciences&#8217; revenue and profit for Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Krishna Institute of Medical Sciences reported revenue of Rs 1,196 crore and a net profit of Rs 37 crore for the quarter ended June 30, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Krishna_Institute_of_Medical_Sciences_declare_a_dividend_with_its_Q1_FY27_results\"><\/span><strong>Did Krishna Institute of Medical Sciences declare a dividend with its Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No interim dividend was declared alongside Krishna Institute of Medical Sciences&#8217; Q1 FY27 results. Investors should track the company&#8217;s next annual results for any dividend announcement.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_does_Krishna_Institute_of_Medical_Sciences_not_have_a_meaningful_PE_ratio\"><\/span><strong>Why does Krishna Institute of Medical Sciences not have a meaningful PE ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Krishna Institute of Medical Sciences does not carry a meaningful price-to-earnings ratio currently because of its recent earnings performance. Investors should use revenue and book value trends instead when assessing the stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_for_Krishna_Institute_of_Medical_Sciences_investors_right_now\"><\/span><strong>What are the key risks for Krishna Institute of Medical Sciences investors right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The quarter&#8217;s profit trend is the clearest risk here. Until Krishna Institute of Medical Sciences shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results. As a multi-specialty hospital care business, Krishna Institute of Medical Sciences&#8217; results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Krishna Institute of Medical Sciences share price well before the next result.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Krishna_Institute_of_Medical_Sciences_promoter_shareholding\"><\/span><strong>What is Krishna Institute of Medical Sciences&#8217; promoter shareholding?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Promoter holding in Krishna Institute of Medical Sciences stood at 32.5% as of the June 2026 quarter.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Krishna Institute of Medical Sciences Q1 FY27: revenue Rs 1,196 crore, PAT Rs 37 crore. Full results breakdown and whether the stock is a buy at current levels.<\/p>\n","protected":false},"author":36,"featured_media":230452,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802],"class_list":["post-230454","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["230452"],"_edit_lock":["1788499908:36"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["69"],"rank_math_title":["Krishna Institute of Medical Sciences share price: Good Buy Now?"],"rank_math_description":["Krishna Institute of Medical Sciences Q1 FY27 results: PAT down 56% to Rs 37 crore, revenue at Rs 1,196 crore. Full results breakdown and valuation check inside."],"rank_math_focus_keyword":["Krishna Institute of Medical Sciences share price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["36"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["41569"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/is-krishna-institute-of-medical-sciences-a-good-buy-after-q1-fy27-results.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/230454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=230454"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/230454\/revisions"}],"predecessor-version":[{"id":230882,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/230454\/revisions\/230882"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/230452"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=230454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=230454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=230454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}